TCL Archive Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks July 25, 2014
TCL Archive Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s. October 26, 2001